Tofacitinib 5 MG

Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL

Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study

Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study

ToFAcitinib in Early Active Axial SpondyloarThritis:

3T Therapy in the Treatment of MDA5-positive Dermatomyositis

Efficacy and Safety of Tofacitinib in Patients With Prurigo Nodularis

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Baricitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Comparison With Tofacitinib

Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis

Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis

Tofacitinib as a GC Sparing Agent for Polymyalgia Rheumatica

Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) Treatment

Risk of Tuberculous and Other Infections in Patients of Spondyloarthritis Treated With Tofacitinib in Bangladesh

Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis

Tofacitinib Bioequivalence Study Comparing Tablets And Capsules